Geng Liu

This paper uses bibliometric analysis to map the evolution of immunomodulatory biomaterials in implant osseointegration from 2005 to 2025, identifying key trends and future directions.

IntroSpect improves HLA binding peptide identification sensitivity by 80% using motif-guided database building, while maintaining high accuracy and FDR control.

EPIP predicts MHC-I epitope presentation by integrating mass spectrometry-derived motifs and tissue-specific RNA-seq data, outperforming existing methods in independent validation.

The paper develops a computational pipeline to identify high-frequency neoantigens in breast cancer and validates their immunogenicity using healthy donor blood samples.